Search Results 1651-1660 of 23535 for Lesion
AFP > 200 and radiological evidence (arterial hypervascularity) of lesion > 2 cm does not require biopsy;; Two imaging modalities (triphasic CT, MRI ...
... lesion. In addition, as necessitated by the risks of Magnetic Resonance Imaging (MRI), patients who have any type of implanted electrical device (such as a ...
... lesion is required within 35 days prior to start of study treatment. HER2+ disease as determined by a tissue based assay performed at a central laboratory ...
... lesions in prostate MRI. PLoS One. 2022; 17 (5):e0268829 Epub 2022 May 23. View PubMed; Takahashi H, Vikram R, Jimenez RE, Bolan CW, Kawashima A, Karam JA ...
Lesion previously treated within the draining lymph node echelon), with macroscopic gross resection of all disease; High risk CSCC, as defined in the ...
... lesion (≥ 10 mm in longest diameter) or with multiple injectable lesions that in aggregate have a longest diameter of ≥ 10 mm. Males or females, age ≥ 18 ...
... lesions;; Total bilirubin (TBIL) ≤ 1.5 x ULN;; For patients not receiving ... lesion on Papanicolaou (PAP) smear, in situ prostate cancer (with no ...
* At least one measurable target lesion * co-infected with HBV and HCV are ... lesions within 7 days prior to initiation of study treatment. Note ...
Prior irradiation if only one target lesion (i.e., measurable) is available, unless progression of the lesion has been confirmed. Known myopathy. History of ...
... lesion or bone lesions as the only evidence for plasma cell dyscrasia, myelodysplastic syndrome or a myeloproliferative neoplasm or light chain amyloidosis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!